MAPS/Lykos: A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

Trial Status:

Completed

Sponsor:

Lykos Therapeutics

ClinicalTrials.gov:

NCT03537014